Ulcerative Colitis

Simponi approved for ulcerative colitis

(HealthDay)—Simponi (golimumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with moderate-to-severe ulcerative colitis.

Medications created May 15, 2013 | popularity not rated yet | comments 0

Flu vaccine safe for children with IBD, study shows

Influenza immunization rates in children with inflammatory bowel disease (IBD) are low despite its safety according to a new study by researchers at the Institute for Clinical Evaluative Sciences (ICES), Children's Hospital ...

Pediatrics created May 06, 2013 | popularity not rated yet | comments 0

Inflammatory bowel disease detection enhanced with PET/CT

Inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, may be detected and monitored more effectively in the future with positron emission tomography/computed tomography (PET/CT), according to ...

Diseases, Conditions, Syndromes created May 01, 2013 | popularity not rated yet | comments 0

Frequently used biologic agents might cause acute liver injury

A commonly used class of biologic response modifying drugs can cause acute liver injury with elevated liver enzymes, according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journa ...

Diseases, Conditions, Syndromes created Apr 29, 2013 | popularity not rated yet | comments 0

Thymus teaches immune cells to ignore vital gut bacteria

The tiny thymus teaches the immune system to ignore the teeming, foreign bacteria in the gut that helps you digest and absorb food, researchers say.

Immunology created Apr 29, 2013 | popularity 4.7 / 5 (3) | comments 0 | with audio podcast

Large-scale genetic study defines relationship between primary sclerosing cholangitis and other autoimmune diseases

For the first time, scientists show that a leading cause of liver transplant, primary sclerosing cholangitis (PSC), is a distinct disease from inflammatory bowel disease, opening up new avenues for specific PSC treatments.

Genetics created Apr 21, 2013 | popularity not rated yet | comments 0 | with audio podcast

Fecal transplant studied for kids with bowel disease

(HealthDay)—Fecal transplantation—an innovative enema treatment—may help reduce or eliminate symptoms of ulcerative colitis in most children and young adults, according to a small study.

Diseases, Conditions, Syndromes created Apr 17, 2013 | popularity 5 / 5 (1) | comments 1

Emu oil may help in common bowel diseases

New research is showing that emu oil has therapeutic potential for the treatment of a variety of common bowel diseases in addition to the intestinal damage caused by cancer chemotherapy.

Medical research created Apr 15, 2013 | popularity 5 / 5 (1) | comments 0

Researchers use atomic force microscopy to decode secrets of our gut

A new technique based on atomic force microscopy was developed at the Institute of Food Research to help 'read' information encoded in the gut lining.

Medical research created Apr 12, 2013 | popularity 4 / 5 (1) | comments 0

Fecal microbial transplantation found to be possible treatment

A Spectrum Health clinical trial has found that fecal microbial transplantation (FMT) has resulted in the improvement or absence of symptoms in most pediatric patients with active ulcerative colitis.

Diseases, Conditions, Syndromes created Apr 05, 2013 | popularity not rated yet | comments 0

Study assesses work force burden of ulcerative colitis

(HealthDay)—Compared to the general population, patients with ulcerative colitis (UC) miss more work days, and patients who undergo colectomy do not fully restore work ability, according to research published ...

Diseases, Conditions, Syndromes created Apr 01, 2013 | popularity not rated yet | comments 0

Researchers find link between blood clotting, immune response

Rice University researchers have found an unexpected link between a protein that triggers the formation of blood clots and other proteins that are essential for the body's immune system. The find could lead ...

Immunology created Apr 01, 2013 | popularity 4.7 / 5 (3) | comments 0 | with audio podcast

Advances in inflammatory bowel disease—what's new, what's next

Every five years, the Crohn's & Colitis Foundation of America (CCFA) gathers top researchers in inflammatory bowel disease (IBD) to set the research agenda for the next five years. The findings and recommendations of these ...

Diseases, Conditions, Syndromes created Mar 22, 2013 | popularity not rated yet | comments 0

Research supports promise of cell therapy for bowel disease

Researchers at Wake Forest Baptist Medical Center and colleagues have identified a special population of adult stem cells in bone marrow that have the natural ability to migrate to the intestine and produce intestinal cells, ...

Medical research created Feb 28, 2013 | popularity not rated yet | comments 0

Study finds no tie between acne drug accutane and Crohn's, colitis

(HealthDay)—A new study counters the notion that the prescription acne drug Accutane raises the risk of Crohn's disease or colitis in women.

Diseases, Conditions, Syndromes created Feb 20, 2013 | popularity not rated yet | comments 0


Ulcerative colitis (Colitis ulcerosa, UC) is a form of inflammatory bowel disease (IBD) . Ulcerative colitis is a form of colitis, a disease of the colon (large intestine), that includes characteristic ulcers, or open sores. The main symptom of active disease is usually constant diarrhea mixed with blood, of gradual onset. IBD is often confused with irritable bowel syndrome (IBS), a troublesome, but much less serious, condition. Ulcerative colitis has similarities to Crohn's disease, another form of IBD. Ulcerative colitis is an intermittent disease, with periods of exacerbated symptoms, and periods that are relatively symptom-free. Although the symptoms of ulcerative colitis can sometimes diminish on their own, the disease usually requires treatment to go into remission. Ulcerative colitis occurs in 35–100 people for every 100,000 in the United States, or less than 0.1% of the population. The disease is more prevalent in northern countries of the world, as well as in northern areas of individual countries or other regions. Although ulcerative colitis has no known cause, there is a presumed genetic component to susceptibility. The disease may be triggered in a susceptible person by environmental factors. Although dietary modification may reduce the discomfort of a person with the disease, ulcerative colitis is not thought to be caused by dietary factors. Ulcerative colitis is treated as an autoimmune disease. Treatment is with anti-inflammatory drugs, immunosuppression, and biological therapy targeting specific components of the immune response. Colectomy (partial or total removal of the large bowel through surgery) is occasionally necessary, and is considered to be a cure for the disease.

This text uses material from Wikipedia and is available under the GNU Free Documentation License.

Latest Spotlight News

Researchers identify a potential new risk for sleep apnea: Asthma

Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...

Study finds that sleep apnea and Alzheimer's are linked

A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.

Computational tool translates complex data into simplified 2-dimensional images

In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...

New theory on genesis of osteoarthritis comes with successful therapy in mice

Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...

'Gap' for HIV vaccine efforts after latest setback

The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.

Ketamine shows significant therapeutic benefit in people with treatment-resistant depression

Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...

Consuming coffee linked to lower risk of detrimental liver disease, study finds

Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...

Returning genetic incidental findings without patient consent violates basic rights, experts say

Informed consent is the backbone of patient care. Genetic testing has long required patient consent and patients have had a "right not to know" the results. However, as 21st century medicine now begins to use the tools of ...

Vicious cycle: Obesity sustained by changes in brain biochemistry

With obesity reaching epidemic levels in some parts of the world, scientists have only begun to understand why it is such a persistent condition. A study in the Journal of Biological Chemistry adds substantially to the st ...

White matter imaging provides insight into human and chimpanzee aging

(Medical Xpress)—The instability of "white matter" in humans may contribute to greater cognitive decline during the aging of humans compared with chimpanzees, scientists from Yerkes National Primate Research ...